Ranbaxy Pharmaceuticals Inc
May 28, 2012 at 11:26 | Source: Moneycontrol.com
May 17, 2012 at 10:12 | Source: Reuters
May 16, 2012 at 12:41 | Source: Moneycontrol.com
May 15, 2012 at 15:05 | Source: Moneycontrol.com
May 11, 2012 at 14:31 | Source: Moneycontrol.com
May 10, 2012 at 18:30 | Source: CNBC-TV18
News across the web »
Dec 20, 2011 at 18:36 | Source: Business Today
Dec 20, 2011 at 18:36 | Source: Business Today
Dec 06, 2011 at 17:21 | Source: The Hindu BusinessLine
Dec 01, 2011 at 12:44 | Source: Money Rediff News Report
Dec 01, 2011 at 12:31 | Source: The Hindu BusinessLine
Interact & exchange stock tips & market info »
Drug firm Ranbaxy Laboratories today launched a generic version of Cad...
1.04 PM Dec 7th 2011
Suspense over Ranbaxy’s Lipitor has finally been lifted. The company...
12.55 PM Dec 1st 2011
Related News »
Under the agreement with Ranbaxy, Cipher is responsible for product supply and manufacturing. About Cipher Pharmaceuticals Inc. Cipher Pharmaceuticals (TSX: DND; OTC: CPHMF.PK) is a growing specialty pharmaceutical company that commercializes ...
May 28, 2012 at 03:28 | Source: Yahoo Finance
Janssen Pharmaceuticals Inc., sued Germany-based Haupt Pharma AG's U.S. unit, Haupt Pharma Inc., as well as India-based Ranbaxy Laboratories Ltd. and its New Jersey-based unit, Ranbaxy Laboratories Inc. Janssen alleges the generics makers filed abbreviated ...
May 23, 2012 at 17:10 | Source: site.law360.com
In August 2008, Cipher Pharma granted Ranbaxy Pharmaceuticals Inc. exclusive right to market, sell and distribute CIP-Isotretinoin in the United States, its territories and possessions. Following the FDA acceptance of the amended NDA as a complete response ...
May 14, 2012 at 07:55 | Source: RTT News
U.S. patent protection on the drug ended on Nov. 30. Watson Pharmaceuticals Inc. makes the authorized generic version in the U.S., and India's Ranbaxy Laboratories Ltd. is selling the only other approved version of the drug. Mylan and other ...
May 27, 2012 at 10:25 | Source: Yahoo Finance
U.S. stocks fell on Friday after a sloppy debut by Facebook Inc spoiled hopes that a spectacular ... its investors to hang up on the country. (Economic Times) PHARMACEUTICALS * Ranbaxy Laboratories plans to re-launch its former flagship skincare ...
May 21, 2012 at 03:29 | Source: Reuters
Five sectors have helped prop up the numbers for India Inc in an otherwise dismal quarter ended March ... information technology (IT), pharmaceuticals and fast moving consumer goods (FMCG). Take these out, and the net profit of the sample size sees ...
May 13, 2012 at 19:17 | Source: Business Standard